Functional germline variants in DNA damage repair pathways are associated with altered survival in adults with glioma treated with temozolomide.
Saved in:
| Title: | Functional germline variants in DNA damage repair pathways are associated with altered survival in adults with glioma treated with temozolomide. |
|---|---|
| Authors: | Guerra G; Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA., Wendt G; Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA., McCoy L; Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA., Hansen HM; Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA., Kachuri L; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Department of Epidemiology & Population Health, Stanford University School of Medicine, Stanford, CA, USA., Molinaro AM; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA.; Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA., Rice T; Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA., Guan V; School of Pharmacy, University of California San Francisco, San Francisco, CA, USA., Capistrano L; School of Pharmacy, University of California San Francisco, San Francisco, CA, USA., Hsieh A; School of Pharmacy, University of California San Francisco, San Francisco, CA, USA., Kalsi V; School of Pharmacy, University of California San Francisco, San Francisco, CA, USA., Sallee J; School of Pharmacy, University of California San Francisco, San Francisco, CA, USA., Taylor JW; Department of Neurology, University of California San Francisco, San Francisco, CA, USA.; Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA., Clarke JL; Department of Neurology, University of California San Francisco, San Francisco, CA, USA.; Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA., Almaraz ER; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA.; Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA., Wiencke JK; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA.; Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA., Eckel-Passow JE; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA., Jenkins RB; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Wrensch M; Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA., Francis SS; Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA.; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA.; Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA. |
| Source: | Neuro-oncology [Neuro Oncol] 2025 Jun 21; Vol. 27 (5), pp. 1385-1398. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
